Press Releases

Press Releases

Schrödinger Announces Pricing of Initial Public Offering

NEW YORK --(BUSINESS WIRE)--Feb. 5, 2020-- Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the pricing of its initial public
February 5, 2020

Schrödinger and Bayer Collaborate to Co-Develop de novo Design Technology to Accelerate Drug Discovery

NEW YORK--( BUSINESS WIRE )--Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive  de novo  design solution with the objective to accelerate the discovery of innovative high-quality drugs. The technology is expected to be capable of
January 8, 2020
Displaying 11 - 12 of 12
Back To Top